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have a dilated left ventricle, reduced systolic function and 
elevated filling pressures. These findings uggest that this 
diastolic filling pattern is a nonspecific response to a dilated 
left ventricle (and probably four chamber dilation), raising 
the possibility that myocardial or pericardial restraining 
forces may, in part, be responsible. In fact, experimentally 
in acute left ventricular dysfunction, pericardial restraint has 
been demonstrated (6). 
Using our model of acute severe left ventricular dysfunc- 
tion (produced by coronary artery microsphere emboliza- 
tion), we demonstrated (9)that the preload-reducing agent 
nitroglycerin resulted in late diastolic filling enhancement 
associated with a smaller left ventricle and a downward and 
leftward shift of the left ventricular p essure-area r lation, 
strongly suggesting reduced pericardial restraining forces. 
However, it is not clear how an agent that improves inotro- 
pit status, and presumably left ventricular relaxation, will 
affect the pattern of diastolic filling. It is our hypothesis tbat, 
in acute severe left ventricular dysfunction with elevated left 
ventricular filling pressures, diastolic filling would be redis- 
tributed to later in diastole in response to hemodynamic 
improvement. 
To test this hypothesis, we utilized an experimental 
canine model of acute severe left ventricular dysfunction 
produced by left main coronary artery microsphere embo- 
lization, and infused an inotropic agent (dobutamine) or a 
vasodilator (nitroprusside) to assess the impact on left ven- 
tricular systolic and diastolic function. 
s 
rhnen tion. The dogs used in this study 
were maintained in accordance with the guidelines of the 
Committee on Animal Studies at Wayne State Llniversity 
School of Medicine and those prepared by the Committee on 
Care and ‘Jse of Laboratory Animals of the Institute of 
Laboratory Animal Resources, National Research Council 
(NHEW Publication no. (NIH) 85-23, revised 1985). 
Twenty-one mongrel dogs (18 to 27 kg) were anesthetized 
with intravenous sodium pentobarbital (30 m&kg body 
weight), intubated and artificially ventilated with a Harvard 
respirator utilizing room air. A 7F high fidelity left ventric- 
ular pressure catheter (Millar Instruments) was introduced 
into the left carotid artery and guided by means of fluoros- 
copy into the left ventricle. A no. 8 Judkins left coronary 
catheter was introduced through an arterial sheath (Cordis) 
into the right femoral artery and advanced into the left 
coronary ostium under fluoroscopic guidance. Small bolus 
injections ofnonionic ontrast medium were used to verify 
its position. Femoral artery pressure was obtained from the 
side arm of the arterial sheath. A7F Sow-directed thermodi- 
lotion ptrlmonaty artery catheter was inserted through the 
right femoral vein and advanced into the pulmonary artery 
under fluoroscopic guidance. The proximal port was con- 
nected to a &rid-filled pressure 
femoral artery pressure 
ogs were then allowed t 
of e~~o~ardiog~~bic, 
were assigned toeither a ‘*no inte~e~tio~*’ 
a uitroprusside infusion group or a dobu 
group. Dogs assigned tothe “no i~te~emtio~” 
a 50 ml infusion of 5% dextrose inwater for 
time the preceding measurements were re 
nitroprusside group received an infusion 
(delivered by a Harvard infusion pump) tit 
ventricular end-diastolic pressure to< 15 
dose of 11.6 f 2.8 &kg per min in a total v 
hemodyaamics. The infusion was contiuued 
30 min to achieve hemodynamic stabihty, 
echocardiographic, ECG, hemodynamic and cardiac output 
variables was then repeated. 
was calculated as: 
A - ~SA)lStro~e ar a 
an 
FF at 112 D = (!/I! DA - ~§A)/Stro~e area, 
If the time of 113 or l/2 diastole occurred ~etwec~ frames, 
linear ~~te~olation between the two closest frames was used 
to calculate the ventricular short-axis area at PI3 or 9% of 
EDA (cm’) Control 9.9 c 2.6 14.9 !: 2.5 
NTP 8.5 f 1.3 12.3 Lt 1.3 
OB 10.4 f 3.3 16.7 I 2.8 
ESA (cm? Control 6.2 f 2.0 12.2 = 2.0 
TP 5.2 ?; I.1 10.8) + 1.3 
CB 1.2 c 2.0 13.0 f 2.3 
AEF (e/n) Conlrol 38.2 f 4.6 19.7 + 4.3 
NT 38.4 r 8.7 18.8 d 3.6 
DO 36.6 + 8.8 17.2 r 3.2 
LVSP (mm Ngb Conlrol 146 t 24 113 4 22 
NTP 136 2 18 II4 + 19 
DOB 156 2 22 102 b: 31 
Peak +dP/dt Control 2,450 + 437 1,458 f 250 
NTP 2,421 + 374 1.579 + 319 
DOB 2,335 t 388 1.325 + 417 
CO (literslmin) Comrel 3.8 2 1.9 2.4 + 1.2 
NTP 3.3 2 0.8 2.0 + 0.4 
DOB 3.1 ” 1.3 1.8 4 0.6 
end-diastolic area; ESA = end-systolic area; LVSP = left ventricular SYSlOliC 
pressure; NTP = ;,itroprusside; + dP/dt = positive first derivative of left 
ventricular pwssure. 
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Table 2. Variables of Left Ventricular Diastolic Function in the 
Three Treatment Groups 
Grouas Baseline CHF p Value 
FF-113D (o/o) 
FPIdD (%) 
LVEDP 
(mm Hg) 
Peak -dP/dt 
(mm Hgls) 
T (ms) 
Mean RAP 
(mm HB) 
DFP (ms) 
IRP (ms) 
RR (ms) 
Control 
NTP 
DOB 
Control 
NTP 
DOB 
Control 
29.0 + 11.3 44.7 + 12.0 
28.4 f 7.1 52.4 f 10.0 
29.7 + 9.4 44.2 A 8.0 
54.0 + 14.2 13.5 2 11.7 
41.2 f 7.2 14.6 f 1.9 
45.5 + 11.3 71.1 ic II.1 
823 22 2 4 
NTP 
DOB 
Control 
NTP 
DOB 
Control 
NTP 
DOB 
Control 
NTP 
DOB 
Control 
NTP 
DOB 
Control 
NTP 
DOB 
Control 
NTP 
DOB 
622 24 + 5 
g+4 26 + 10 
-2,483 + 422 - 1,350 + 316 
-2,319 f 418 -1,235 f 319 
-2,564 2 394 -1,264 f 372 
32 + 10 63 * 1 
31 i: 13 79 ” 20 
32 2 7 83 f 25 
3+2 754 
3+1 6?2 
322 7+3 
156 f 51 I55 + 75 
135 f 24 133 2 25 
143 + 43 1335 34 
34 f 22 65 + 22 
39 f 12 16 k 22 
50 2 26 75 + 24 
413 f 75 450 ?: 84 
428 f 44 434 + 45 
465 f 16 431 + 14 
co.05 
-co.01 
co.05 
CO.01 
<O.Ool 
60.001 
CO.001 
~0,001 
<O.OOl 
:0.001 
aom 
co.001 
co.01 
<O.ODl 
~0.001 
co.05 
co.01 
co.01 
NS 
NS 
NS 
co.05 
co.05 
<0.05 
NS 
NS 
NS 
DFP = diastolic filling period; FF-113D =filling fraction at l/J of diastole: 
FF-IRD = filling fraction at 112 of diastole: IRP = isovolumic relaxation 
period; LVEDP = left ventricular end-diastolic pressure: -dP/dt = negative 
first derivative of left ventricular p essure; RAP = right atrial pressure; RR = 
cycle length; T = time constant of left ventricular p essure decline; other 
abbreviations as in Table 1. 
ventricular dysfunction, there was an increase in left ven- 
tricular size and a reduction i systolic function as charac- 
terized by a decrease in peak positive dP/dt and area ejection 
fraction for all groups. Only global hypokinesia was noted at 
multiple short-axis levels. Cardiac output and left ventricular 
systolic pressure also declined with acute left ventricular 
dysfunction i  all three groups. In ail groups, variables ofleft 
ventricular size and systolic function were comparable at
baseline study and after the production of severe left ven- 
tricular dysfunction. 
lc function. The elect of production ofsevere left 
ventricular dysfunction on diastolic function variables i
summarized in Table 2. For ail groups, an increase inextent 
of early diastolic filling characterized by an increase infilling 
fraction at 113 and 112 of diastoie was noted and was 
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Figure 1. Percent stroke volume filled plotted against the percent of 
diastole during baseline ( 
heart failure Q-IF) for 
prusside, dobutamine or control group. Diastolic fi
tributed to earlier in diastole during congestive h art failure. 
associated with a marked im ent in left ventricular 
relaxation and compliance as suggested 
end-diastolic pressure, an increase in th 
left ventricular pressure decline, a 
negative dP/dt and a marked ~ghtwa~d 
the pressure-area curve. Figure I, a re 
the percent of stroke volume filled t 
baseline study and during acute congestive heart fa 
either control or intervention dogs, dem~~st~tes a 
bution of diastolic filling to early diastole with the production 
of acute left ventricular dysfunction. Figure 2, a repre- 
sentative plot of pressure versus area at baseline study and 
during congestive h art failure for either control or interven- 
tion dogs, demonstrates a rightward and upward shift of the 
pressure-area plot with acute left ventricular dysfunction. A 
prolongation of the isovolumetric relaxation period was 
noted in all groups with acute left ventricular dysfunction. 
Heart rate and diastolic filling period were unchailged with 
acute left ventricular dysfunction. The mean right atria1 
Figure 2. Simultaneous left ventricular pressure and echocardio- 
graphic left ventricular area plotted for a representative dog at 
baseline (BASE) study and during acute congestive heart failure 
U-IF) for either the nitroprusside, obutamine or control group. An 
upward and rightward shift of the pressure-area curve was noted 
during congestive h art failure. 
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CHF intervention p Value 
EDA (cm2) 
ESA (cm’) 
AEF (%) 
Peak tdP/dt 
CO (literslmin) 
NTP 
DOB 
Control 
NW 
DOB 
Control 
NTP 
DOB 
NW 
DOB 
Control 
NTP 
DOB 
14.9 -c 2.5 
13.3 f 1.3 
16.7 f 2.8 
12.2 r 2.0 
13.8 t 2.3 
19.7 f 4.3 
18.8 2 3.6 
17.2 2 3.2 
113 ” 22 
112 f 31 
1,458 c 2.50 
1.599 f 319 
1.325 i: 417 
2.4 2 1.2 
2.0 r 0.4 
1.8 f 0.6 
14.0 2 2.0 NS 
11.8 k 1.2 co.05 
15.4 f 3.1 S 
11.1 t 1.3 NS 
9.3 f 1.2 c0.05 
If.9 + 3.c K0.05 
20.6 + 3.2 MS 
21.4 + 5.6 NS 
22.9 + 5.0 
103 -c 3s NS 
86~ 15 CO.01 
122 c 25 NS 
1.250 t 293 NS 
8,4tM I391 NS 
2,O32 f 616 <o.OOt 
2.0 t 1.0 NS 
2.4 t 0.6 c0.05 
2.4 2 0.8 co.05 
Abbreviations as in Table 1. 
Peak -dlPldt 
(mm l-&Is) 
T tms) 
Mean RAP 
(mm H@ 
DFP (ms) 
IRP (ms) 
Control 44.7 ? 12.0 
NTP 
DO 
@OflWOl 93.5 + 11.7 
NW 74.6 2 7.9 
DOB 71.1 + 11.1 
Control 22 2 4 
N-W 24 f 5 
OB 26 + 1 
Control - 1,350 f 316 
NW - 1.235 k 319 
DOB - I.204 t 372 
COFlWOl 63 * 7 
NTP 79 f 20t 
DOB 83 + 25i 
Control 7c4 
NnJ 
DOB 
Control 
NTP 
DOB 
CWI?rol 
NTP 
DOB 
Control 
NTP 
DOB 
622 
723 
‘r55 r 75 
133 + 25 
133 f 34 
65 f 32 
96 f 22 
75 f 24 
450 f 84 
434 z 45 
431 -c 74 
50.6 + 16.9 
19.4 + 9.4$ 
18 r 7.41 
80.0 r 13.4 
39.6 2 6.Q$ 
33.5 t 9.5$ 
24 t 5 
14 f 2t 
26 + 101 
-I,iliO !I 351 
-I, 2 283 
- 1,646 -c 4OO*$ 
60% 12 
55 t 18 
63 1?: 21 
3 rt: 2’r 
123 
co.01 
NS 
181 + 98 MS 
155 i: 59 NS 
157 ” 33 NS 
52 f 50 
53 + 19 
65 2 26 
NS 
CO.05 
NS 
456 + 91 
435 2 
416 I 3: 
NS 
NS 
NS 
CO.001 
NS 
NS 
NS 
co.05 
NS 
<O.QQl 
<O.QP 
NS 
e 
reduction i  keft ventricular size and systolic pres asso- 
ardiac output, and a I1 but 
ve~t~c~iar systolic functton as 
ectian fraction. In the dobutamine- 
treated group, end-systolic volume was smaller and area 
ejection fraction, peak positive dP/dt and cardiac output 
indicating an inotropic response to tke dobu- 
tion in left ve~t~c~lar ~~d..d~dst~~ic pressure and Size pro- 
sion was associated with a 
112) filling fractions and 
treated group, a marked reduction i  filling fractions and the 
5 and tp c 0.31 versus control; Sp < O.Q5 and $p < O.Ql 
do~utam~~e versus nitroprusside. Abbreviations as in Table 2. 
was not associated with a change in 
with infusion of either dobutamine orni 
pared with the control group after 1 h o 
acute left ventricular ~y~f~ncti~~. 
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Mpre 3. Percent sfroke volume filled throughout diastole plotted for 
two representative dogs in the nitroprusside (CHF [NTP])- and 
dobutamine (CHF [DOB])-treated groups after coronary micro- 
sphere mbolization (up r curves]. The lower curves represent the 
time course of diastolic filling after infusion of nitroprusside (NTP) 
or dobutamine (DOB). Early diastolic filling is reduced with infusion 
of either agent and is redistributed to later in diastole. 
Figure 4 is a representative pressure-area plot for dogs in 
the nitroprusside-treated group (top) and dobutamine- 
treated group (bottom) with acute left ventricular dysfunc- 
tion and during treatment infusions. Nitroprusside infusion 
produced a downward and leftward shift in the pressure-area 
Simultaneous left ventricular p essure and echocardio- 
eft ventricular ea plotted for two representative dogs 
during acute congestive h art failure (CHP) and during nitroprusside 
(NTP) and dobutamine (DOB) infusion. A downward and leftward 
shift of the pressure-area curve was noted during prusside 
infusion (upper graph). Dobutamine infusion (lower ) shifted 
the initial portion of the pressure-area curve downward and left- 
ward. The curves parallel ( eftward) each other during later diastole. 
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plot. Dobutamine infusion shited the initi 
pressure-area curve leftward an 
smaller end-systolic volume an 
pressure. No changes were noted 
1 h of observation in the control dogs. 
Peak negative dP/dt increased urin 
infusion, probably secondary to improv 
cardial pressure. 
Systole and diastole are two energ 
processes. Abnormalities of systolic 
ity can be expected to be accom~a~~e 
With severe left ventri 
ities of contractility a 
nied by abnormalities of diastolic function, 
pericardium and right ventricle). These factors may cant 
ute to the symptoms of pulmonary congestion and 
elevation of the intracavitary left ventricular end-diastolic 
pressure. Pharmacologic therapy for congestive heart failure 
due to left ventricular dysfunction, targeted at increasing 
contractility or reducing preload and afterload, improves 
systolic performance and reduces ymptoms. Because ab- 
normalities of systolic function are often interrelated to
abnormalities of diastolic functicn, itwould see 
inotropic or load-reducing (vasodilator) therapy should alter 
s of diastolic function. 
~ys~u~~t~o~. In this study, nitroprusside, anafterload- and 
preload-reducing agent, improved hemodynamics in this 
canine model of acute severe left ventricular dysfunction by 
reducing systemic arterial pressure, reducing left ventricular 
end-diastolic pressure and size at end-diastole and at end- 
systole and increasing cardiac output. These hemodynamic 
alterations were associated with an improvement in the 
invasive and noninvasive ariables ofrelaxation, shifted the 
pressure-volume relation downward and leftward and redis- 
tributed iastolic filling to later in diastole. ~obatami~e 
increased cardiac output, left ventricuhr area ejection frac- 
tion and peak negative dP/dt and reduced end-systohc size. 
These hemodynamic alterations were associated with im- 
proved invasive variables of relaxation, a leftward and 
slightly downward initial shift of the pressure-area curve 
during early diastole (as a result of a smaller end-systolic 
volume) and redistribution of diastolic filling to later in 
filling to later in diastole in association with decreased right 
atria1 pressure, reduced left ventricular end-diastolic p 
aller left ventricular end-diastolic and 
systolic volumes (9). in results to indicate 
that diastolic filling ati by pharmacologic 
manipulations may be secondary to reduced pericardial 
restraining forces. 
Because the transmitraii pressure gradient may be the 
most impo~a~t determinant ofdiastolic filling (151, we might 
expect hat the early transmitral pressure gradient would be 
decreased probably secondary to a decrease in % 
pressure at the time of 
not measure l ft atria! 
neous mitral valve ec 
and obtained left ventricular p essure a 
as an estimate of the left atrial pressure at 
opening. Left ~ventricular pressure at mitral valve opening 
(29 f 6 versus 17 + 4 mm Hg, p < O.QOw)1) and the pressure 
difference between left ventricular pressure at the time of 
iastdic left atria&-l 
not decrease as t 
e alterations wrt 
rapy. The peak filling rate 
dob~tamine, but was no 
slow for MS to discer 
r tbe peak rate of diastoli ling was increased wit 
dob~tamine i fusion, we were able to discern that diastolic 
distributed tolater in diastol 
nitroprusside interventions. 
diastolic filling to later in diastole was als 
of the radionuclide curves in the study of 
addition to increasing 
ment of congestive he 
ecause this was a closed chest study, we 
~misetb etal. (13.1 
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pressure measurement may be obtained by use of a flat 
balloon (13,1$) that can measure contact Stress. 
To conclusively demonstrate the mechanisms for this 
diastolic filring pattern alteration, assessment of the trans- 
mitral pressure gradient is important. In this study, we did 
not obtain left atria1 pressures by means of transseptal 
catheterization. Despite this limitation, we were able to 
estimate l ft atria1 pressure at the time of mitral valve 
opening and the peak early diastolic filling gradient. 
The use of area versus time curves with a 30 frame/s 
resolution produces a limited number of diastolic frames for 
evaluation when the heart rate is 130 to 150 beatslmin. Pulsed 
Doppler echocardiography may be the ideal technique for the 
evaluation f diastolic filling for this study. Unfortunately, in 
a closed chest study, apical views are necessary and are best 
obtained by means of transesophageal echocardiography, 
which was not available atthe time of the study. Despite this 
lack of technology, our limited time resolution area versus 
time curves demonstrated clear alterations in the diastolic 
filling pattern with nitroprusside and dobutamine therapy. 
Because the use of the area versus time curve necessarily 
includes the isovolumetric elaxation period, differences in 
the latter period may affect filling fraction determinations, 
especially with a heart rate > $20 beatslmin when the number 
of diastolic frames may be as low as six or seven. With severe 
left ventricular dysfunction before nitroprusside therapy, the 
isovolumetric elaxation period was 23 ms longer than with 
nitroprusside infusion. This wottld tend to underestimate th
filling fraction during severe l ft dysfunction a d overestimate 
the filling fraction during nitroprussidc infusion. Because the 
filling fractions were markedly ower with nitroprusside infu- 
sion, this limitation does not appear to affect he data. 
Patients with congestive cardiomyopathy may have mi- 
tral regurgitation, which tends to increase the extent and 
rate of early diastolic filling (21). However, in our experi- 
ence with this canine model of acute left ventricular dysfunc- 
tion, we were able to demonstrate only trace or no mitral 
regurgitation with pulsed Doppler echocardiography 
@avine, unpublished observations). Although in this study 
we did not specifically attempt to identify mitral regurgita- 
tion, on the basis of our previous experience, it is unlikely 
that any more than trace mitral regurgitation was present. 
Gme$us$ons. Both dobutamine and nitroprusside resulted 
in similar alterations in the diastolic filling pattern, as chamc- 
terdzed by redistribution f diastolic filling to later in diastole. 
This similarity occurred although t e two interventions utilize 
dserent mechanisms to improve systolic and diastolic per- 
formance inacute severe left ventricular dysfunction, 
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